ATE306547T1 - Menschliche hybrid-wirtszelle zur expression von säugetier-genen - Google Patents
Menschliche hybrid-wirtszelle zur expression von säugetier-genenInfo
- Publication number
- ATE306547T1 ATE306547T1 AT99963067T AT99963067T ATE306547T1 AT E306547 T1 ATE306547 T1 AT E306547T1 AT 99963067 T AT99963067 T AT 99963067T AT 99963067 T AT99963067 T AT 99963067T AT E306547 T1 ATE306547 T1 AT E306547T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- human
- recombinant
- genes
- host cell
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 7
- 230000004927 fusion Effects 0.000 abstract 2
- 230000014509 gene expression Effects 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 210000003292 kidney cell Anatomy 0.000 abstract 2
- 208000011691 Burkitt lymphomas Diseases 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 abstract 1
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 210000004754 hybrid cell Anatomy 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 238000004114 suspension culture Methods 0.000 abstract 1
- 238000001890 transfection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/209,920 US6136599A (en) | 1998-12-10 | 1998-12-10 | Human hybrid host cell for mammalian gene expression |
| PCT/US1999/029332 WO2000034462A1 (en) | 1998-12-10 | 1999-12-08 | Human hybrid host cell for mammalian gene expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE306547T1 true ATE306547T1 (de) | 2005-10-15 |
Family
ID=22780882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99963067T ATE306547T1 (de) | 1998-12-10 | 1999-12-08 | Menschliche hybrid-wirtszelle zur expression von säugetier-genen |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6136599A (de) |
| EP (1) | EP1137768B1 (de) |
| JP (3) | JP4332300B2 (de) |
| KR (1) | KR100627753B1 (de) |
| CN (1) | CN1230532C (de) |
| AT (1) | ATE306547T1 (de) |
| AU (1) | AU757188B2 (de) |
| BG (1) | BG65263B1 (de) |
| BR (1) | BRPI9916095B8 (de) |
| CA (1) | CA2353698C (de) |
| CU (2) | CU23382A3 (de) |
| CZ (1) | CZ302677B6 (de) |
| DE (1) | DE69927707T2 (de) |
| DK (1) | DK1137768T3 (de) |
| ES (1) | ES2249929T3 (de) |
| HU (1) | HU229775B1 (de) |
| ID (1) | ID30448A (de) |
| IL (2) | IL143351A0 (de) |
| NO (1) | NO330548B1 (de) |
| PL (1) | PL205549B1 (de) |
| RO (1) | RO121563B1 (de) |
| RU (1) | RU2228355C2 (de) |
| SI (1) | SI20693B (de) |
| SK (1) | SK287888B6 (de) |
| TR (1) | TR200101642T2 (de) |
| UA (1) | UA77642C2 (de) |
| WO (1) | WO2000034462A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6358703B1 (en) | 1998-12-10 | 2002-03-19 | Bayer Corporation | Expression system for factor VIII |
| US6136599A (en) * | 1998-12-10 | 2000-10-24 | Bayer Corporation | Human hybrid host cell for mammalian gene expression |
| US6348192B1 (en) * | 1999-05-11 | 2002-02-19 | Bayer Corporation | Interleukin-2 mutein expressed from mammalian cells |
| US20040235715A1 (en) * | 1999-11-12 | 2004-11-25 | Bayer Corporation | Method of producing glycosylated bikunin |
| US6569657B1 (en) * | 2000-06-27 | 2003-05-27 | Millennium Pharmaceuticals, Inc. | 32140, a novel human aldehyde dehydrogenase and uses therefor |
| US7094587B2 (en) * | 2000-06-27 | 2006-08-22 | Millennium Pharmaceuticals, Inc. | 16002 Molecules and uses therefor |
| US7723102B2 (en) * | 2000-09-28 | 2010-05-25 | Bayer Corporation | Enhanced transfection system |
| MY139948A (en) * | 2000-09-28 | 2009-11-30 | Bayer Corp | Enhanced transfection system |
| US20060073141A1 (en) * | 2001-06-28 | 2006-04-06 | Domantis Limited | Compositions and methods for treating inflammatory disorders |
| KR100496861B1 (ko) | 2002-09-26 | 2005-06-22 | 삼성전자주식회사 | 하나의 핸들러에 2개 이상의 테스트 보드를 갖는 테스트장비 및 그 테스트 방법 |
| US7285269B2 (en) | 2002-12-02 | 2007-10-23 | Amgen Fremont, Inc. | Antibodies directed to tumor necrosis factor |
| US7244616B2 (en) | 2003-06-27 | 2007-07-17 | Bayer Pharmaceuticals Corporation | Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| US7632921B2 (en) | 2004-11-12 | 2009-12-15 | Bayer Healthcare Llc | Site-directed modification of FVIII |
| WO2008149147A2 (en) | 2007-06-06 | 2008-12-11 | Domantis Limited | Polypeptides, antibody variable domains and antagonists |
| CA2720610C (en) | 2008-04-07 | 2016-08-23 | Bayer Healthcare Llc | Methods of recombinant production of glycoproteins |
| KR101005967B1 (ko) * | 2008-04-12 | 2011-01-05 | (주)셀트리온 | 우수한 재조합 단백질을 생산하기 위한 인간 숙주 세포 |
| US9090948B2 (en) * | 2008-09-30 | 2015-07-28 | Abbott Molecular Inc. | Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples |
| SG176302A1 (en) * | 2009-06-10 | 2012-01-30 | Bts Res Internat Pty Ltd | Methods of generating hybrid/chimeric cells, and uses thereof |
| US11649449B2 (en) | 2015-09-03 | 2023-05-16 | CHO Plus, Inc. | Hybrid cell lines for high level production of a target protein |
| EP3487998B1 (de) | 2016-07-19 | 2023-07-12 | Brandeis University | Zusammensetzungen und verfahren zur identifizierung von rna-bindenden polypeptidzielen |
| US11542329B2 (en) | 2018-05-16 | 2023-01-03 | Morphosys Ag | Antibodies targeting Glycoprotein VI |
| US20220135658A1 (en) | 2019-03-14 | 2022-05-05 | Morphosys Ag | Antibodies targeting c5ar |
| IL288877B2 (en) * | 2019-06-10 | 2024-05-01 | Cho Plus Inc | Cell lines for high-level production of protein-based drugs |
| JP2023542209A (ja) | 2020-09-24 | 2023-10-05 | モルフォシス・アーゲー | ヒトｃｄ３イプシロンに結合する新規なヒト抗体 |
| CN113604425B (zh) * | 2021-06-22 | 2022-10-18 | 中山康天晟合生物技术有限公司 | 一种适应无血清培养基环境的wayne293 lvpro细胞及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6045849B2 (ja) * | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
| JPS6030654B2 (ja) * | 1980-12-31 | 1985-07-17 | 株式会社林原生物化学研究所 | ヒトコロニ−刺激因子の製造方法 |
| US6136599A (en) * | 1998-12-10 | 2000-10-24 | Bayer Corporation | Human hybrid host cell for mammalian gene expression |
-
1998
- 1998-12-10 US US09/209,920 patent/US6136599A/en not_active Expired - Lifetime
-
1999
- 1999-08-12 UA UA2001074776A patent/UA77642C2/uk unknown
- 1999-12-08 RO ROA200100648A patent/RO121563B1/ro unknown
- 1999-12-08 CA CA2353698A patent/CA2353698C/en not_active Expired - Lifetime
- 1999-12-08 DK DK99963067T patent/DK1137768T3/da active
- 1999-12-08 PL PL349625A patent/PL205549B1/pl unknown
- 1999-12-08 EP EP99963067A patent/EP1137768B1/de not_active Expired - Lifetime
- 1999-12-08 ES ES99963067T patent/ES2249929T3/es not_active Expired - Lifetime
- 1999-12-08 BR BRPI9916095A patent/BRPI9916095B8/pt not_active IP Right Cessation
- 1999-12-08 JP JP2000586896A patent/JP4332300B2/ja not_active Expired - Lifetime
- 1999-12-08 ID IDW00200101235A patent/ID30448A/id unknown
- 1999-12-08 CN CNB998142999A patent/CN1230532C/zh not_active Expired - Lifetime
- 1999-12-08 CZ CZ20012023A patent/CZ302677B6/cs not_active IP Right Cessation
- 1999-12-08 IL IL14335199A patent/IL143351A0/xx unknown
- 1999-12-08 WO PCT/US1999/029332 patent/WO2000034462A1/en not_active Ceased
- 1999-12-08 KR KR1020017007224A patent/KR100627753B1/ko not_active Expired - Lifetime
- 1999-12-08 SI SI9920096A patent/SI20693B/sl active Search and Examination
- 1999-12-08 RU RU2001119161/13A patent/RU2228355C2/ru active
- 1999-12-08 HU HU0104681A patent/HU229775B1/hu unknown
- 1999-12-08 DE DE69927707T patent/DE69927707T2/de not_active Expired - Lifetime
- 1999-12-08 TR TR2001/01642T patent/TR200101642T2/xx unknown
- 1999-12-08 SK SK791-2001A patent/SK287888B6/sk not_active IP Right Cessation
- 1999-12-08 AU AU19383/00A patent/AU757188B2/en not_active Expired
- 1999-12-08 AT AT99963067T patent/ATE306547T1/de active
-
2001
- 2001-05-24 IL IL143351A patent/IL143351A/en not_active IP Right Cessation
- 2001-06-06 BG BG105566A patent/BG65263B1/bg unknown
- 2001-06-07 CU CU20010130A patent/CU23382A3/es not_active IP Right Cessation
- 2001-06-07 NO NO20012806A patent/NO330548B1/no not_active IP Right Cessation
-
2002
- 2002-08-26 CU CU20020182A patent/CU23238A1/es unknown
-
2009
- 2009-03-06 JP JP2009053279A patent/JP5508740B2/ja not_active Expired - Lifetime
-
2014
- 2014-02-24 JP JP2014032748A patent/JP5826311B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE306547T1 (de) | Menschliche hybrid-wirtszelle zur expression von säugetier-genen | |
| Tjian et al. | Biological activity of purified simian virus 40 T antigen proteins. | |
| AP1678A (en) | Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems. | |
| ATE369384T1 (de) | Expression und export von interferon-alpha proteinen als fc fusionsproteine | |
| SE0201328D0 (sv) | Hematopoietic differentiation of human embryonic stem cells | |
| DK0789766T3 (da) | Kimæriske papillomaviruslignende partikler | |
| FI820075L (fi) | Rekombination-dna-medel och foerfarande | |
| CN118660958A (zh) | 适应无血清悬浮培养的hek293细胞株及其应用 | |
| JPH04228066A (ja) | 外来遺伝子発現用培養細胞 | |
| Chang et al. | Transformation of human cultured fibroblasts with plasmids carrying dominant selection markers and immortalizing potential | |
| KR890005264A (ko) | 인터류킨-2를 생산하는 재조합 진핵 세포, 그의 제조 방법 및 그의 제조용 벡터 및 인터류킨-2의 제조방법 | |
| NZ329360A (en) | Immortalised retinal derived cell lines capable of being implanted in the retina and carrying a therapeutic substance to the eye and the central nervous system and other applications of the cell thereof | |
| NZ512235A (en) | Human hybrid host cell for mammalian gene expression | |
| DK0870044T3 (da) | Reguleret proteinekspression i stabilt transfekterede pattedyrsceller | |
| JP2507882B2 (ja) | 外部増殖因子非依存性増殖良好細胞株の製造法 | |
| JP2500384B2 (ja) | 生理活性物質の製造法 | |
| Odörfer et al. | Marker tolerant, immunocompetent animals as a new tool for regenerative medicine and long-term cell tracking | |
| Waldman et al. | Transfer of herpes simplex virus thymidine kinase synthesized in bacteria by a high-expression plasmid to tissue culture cells by protoplast fusion | |
| Hohenwarter et al. | Human endothelial cell lines established by mutated forms of the simian virus 40 large T oncogene | |
| Bayley et al. | Immortalization of rat keratinocytes by transfection with polyomavirus large T gene | |
| Miranda et al. | Large-scale production and purification of recombinant protein from an insect cell/baculovirus system in Erlenmeyer flasks: application to the chicken poly (ADP-ribose) polymerase catalytic domain | |
| Lanfranchl et al. | Globin synthesis in heterokaryons formed between chick erythrocytes and human K562 cells or rat L6 myoblasts | |
| JPH0732705B2 (ja) | 動物細胞増殖用組成物およびそれを用いる動物細胞の増殖方法 | |
| AU666800B2 (en) | Process for producing exogenous protein | |
| Colman | Microinjection and organelle transplantation techniques: Methods and applications: edited by JE Celis, A. Graessmann and A. Loyter, Academic Press, 1986.£ 47/$75.50 (hbk)£ 23/$36.95 (pbk)(xi+ 379 pages) ISBN 0 12 164722 6 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1137768 Country of ref document: EP |